Skip to main content
Eprenetapopt and azacitidine combination yields high response rates in TP53-mutant MDS
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Eprenetapopt and azacitidine combination yields high response rates in TP53-mutant MDS
User login
Username
Password
Reset your password
concept
Lead
score
Myelodysplastic Syndrome
1
1
Specialty
Lead
score
Hematology-Oncology
1
1